Mendelian randomization analysis and validation supports MEGF9 and MLLT11 as potential targets for the treatment of varicocele and male infertility.
- DOI
- 10.3389/fendo.2024.1416384
- Published
- 2024
- Container
- Frontiers in endocrinology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fendo.2024.1416384,
title = {Mendelian randomization analysis and validation supports MEGF9 and MLLT11 as potential targets for the treatment of varicocele and male infertility.},
author = {Cai B and Sun D and Deng W and Jin Y and Zhao H and Xing D and Liu Y and Jin B},
year = {2024},
journal = {Frontiers in endocrinology},
doi = {10.3389/fendo.2024.1416384},
url = {https://doi.org/10.3389/fendo.2024.1416384}
}RIS
TY - JOUR TI - Mendelian randomization analysis and validation supports MEGF9 and MLLT11 as potential targets for the treatment of varicocele and male infertility. AU - Cai B AU - Sun D AU - Deng W AU - Jin Y AU - Zhao H AU - Xing D AU - Liu Y AU - Jin B PY - 2024 JO - Frontiers in endocrinology DO - 10.3389/fendo.2024.1416384 UR - https://doi.org/10.3389/fendo.2024.1416384 ER -
APA
B, C., D, S., W, D., Y, J., H, Z., D, X., Y, L., & B, J. (2024). Mendelian randomization analysis and validation supports MEGF9 and MLLT11 as potential targets for the treatment of varicocele and male infertility.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2024.1416384
Source records
- pubmed · retrieved 2026-09-25T19:28:00.689Z